A comparative molecular field analysis (CoMFA) study using semiempirical, density functional, ab initio methods and pharmacophore derivation using DISCOtech on sigma 1 ligands
暂无分享,去创建一个
Dawoon Jung | Jie Floyd | Tamara M. Gund | Dawoon Jung | T. Gund | J. Floyd
[1] Rudolf H. Winger,et al. Comparative molecular field analysis of artemisinin derivatives: Ab initio versus semiempirical optimized structures , 1998, J. Comput. Aided Mol. Des..
[2] Supa Hannongbua,et al. 3D-Quantitative Structure-Activity Relationships of HEPT Derivatives as HIV-1 Reverse Transcriptase Inhibitors, Based on Ab Initio Calculations , 2001, J. Chem. Inf. Comput. Sci..
[3] C. Melchiorre,et al. 1'-Benzyl-3,4-dihydrospiro[2H-1- benzothiopyran-2,4'-piperidine] (spipethiane), a potent and highly selective sigma1 ligand. , 1998, Journal of medicinal chemistry.
[4] Yvonne C. Martin,et al. A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists , 1993, J. Comput. Aided Mol. Des..
[5] Bruce L. Bush,et al. Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA , 1993, J. Comput. Aided Mol. Des..
[6] R. Cramer,et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.
[7] Richard A. Glennon,et al. A CoMFA investigation of sigma receptor binding affinity: Reexamination of a spurious sigma ligand , 1998 .
[8] Magid Abou-Gharbia,et al. Chapter 1. Sigma Receptors and their Ligands: The Sigma Enigma , 1993 .
[9] Shigeru Okuyama,et al. NE-100: A Novel Sigma Receptor Antagonist , 1996 .
[10] Peter D. J. Grootenhuis,et al. Comparative molecular field analysis and energy interaction studies of thrombin-inhibitor complexes , 1999, J. Comput. Aided Mol. Des..
[11] J D Brodie,et al. The selective sigma(1) receptor agonist, 1-(3,4-dimethoxyphenethyl)-4-(phenylpropyl)piperazine (SA4503), blocks the acquisition of the conditioned place preference response to (-)-nicotine in rats. , 2001, European journal of pharmacology.
[12] M L Brown,et al. Comparative molecular field analysis of hydantoin binding to the neuronal voltage-dependent sodium channel. , 1999, Journal of medicinal chemistry.
[13] David T. Manallack,et al. Quantitative conformational analyses predict distinct receptor sites for PCP-like and σ drugs , 1987 .
[14] T. Heffner,et al. The Pharmacology of the Novel and Selective Sigma Ligand, PD 144418 , 1997, Neuropharmacology.
[15] J. Poupaert,et al. 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives: novel, potent and selective sigma1 receptor ligands. , 1997, European journal of pharmacology.
[16] P. Shepard,et al. Effects of NPC16377, a potent and selective sigma receptor ligand, on the activity of mesencephalic dopamine-containing neurons in the rat. , 1994, European journal of pharmacology.
[17] L Morin-Allory,et al. Pharmacophoric search and 3D-QSAR comparative molecular field analysis studies on agonists of melatonin sheep receptors. , 1998, Journal of medicinal chemistry.
[18] Abass Alavi,et al. N-(N-Benzylpiperidin-4-yl)-2-[18F]fluorobenzamide: A potential ligand for PET imaging of σ receptors , 1997 .
[19] A. Debnath,et al. Three-dimensional quantitative structure-activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitors: application of comparative molecular field analysis. , 1999, Journal of medicinal chemistry.
[20] G. Skuza,et al. Neuropharmacological profile of EMD 57445, a sigma receptor ligand with potential antipsychotic activity. , 1996, European journal of pharmacology.
[21] Rikki N. Waterhouse,et al. Halogenated 4-(phenoxymethyl)piperidines as potential radiolabeled probes for σ-1 receptors : In vivo evaluation of [123I]-1-(iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]piperidine , 1997 .
[22] Peter W. Kenny,et al. Prediction of hydrogen bond basicity from computed molecular electrostatic properties: implications for comparative molecular field analysis , 1994 .
[23] Bernhard Wünsch,et al. Novel sigma receptor ligands. Part 2. SAR of spiro[[2]benzopyran-1,4'-piperidines] and spiro[[2]benzofuran-1,4'-piperidines] with carbon substituents in position 3. , 2002, Journal of medicinal chemistry.
[24] W. Bowen,et al. Sigma receptors: biology and function. , 1990, Pharmacological reviews.
[25] D. Manallack,et al. Receptor site topographies for phencyclidine-like and sigma drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analyses. , 1988, Molecular pharmacology.
[26] H Matter,et al. Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis. , 1999, Journal of medicinal chemistry.
[27] Tamara M. Gund,et al. Molecular modeling of sigma receptor ligands: A model of binding based on conformational and electrostatic considerations , 1991 .
[28] Matthew Clark,et al. The Probability of Chance Correlation Using Partial Least Squares (PLS) , 1993 .
[29] Orazio Prezzavento,et al. Synthesis of (+)-cis-N-(4-isothiocyanatobenzyl)-N-normetazocine, an isothiocyanate derivative of N-benzylnormetazocine as acylant agent for the sigma(1) receptor. , 2002, Journal of medicinal chemistry.
[30] B Testa,et al. Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models. , 1996, Journal of medicinal chemistry.
[31] Andrew Coop,et al. N-arylalkylpiperidines as high-affinity sigma-1 and sigma-2 receptor ligands: phenylpropylamines as potential leads for selective sigma-2 agents. , 2002, Bioorganic & medicinal chemistry letters.
[32] Shigeru Okuyama,et al. Effect of NE-100, a novel σ receptor ligand, on phencyclidine-induced cognitive dysfunction , 1994 .
[33] D R Flower,et al. Lead generation using pharmacophore mapping and three-dimensional database searching: application to muscarinic M(3) receptor antagonists. , 1999, Journal of medicinal chemistry.
[34] W. Welsh,et al. Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis. , 1998, Journal of medicinal chemistry.
[35] R. Mailman,et al. Novel (4-phenylpiperidinyl)- and (4-phenylpiperazinyl)alkyl-spaced esters of 1-phenylcyclopentanecarboxylic acids as potent sigma-selective compounds. , 1994, Journal of medicinal chemistry.
[36] R E Wilcox,et al. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors. , 1998, Journal of medicinal chemistry.
[37] A Minarini,et al. Antagonist binding profile of the split chimeric muscarinic m2-trunc/m3-tail receptor. , 1998, European journal of pharmacology.